Summary

Persistence Market Research has recently released an in-depth report on the global Breast Recurrence Score Test Market. This report provides a thorough evaluation of key market dynamics, including drivers, trends, opportunities, and challenges, along with detailed insights into the market structure.

Key Insights:

• Breast Recurrence Score Test Market Size (2024E): USD 259 Million
• Projected Market Value (2033F): USD 576.6 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 9.3%

Scope of the Report: Breast Recurrence Score Test Market

The Breast Recurrence Score Test is essential for guiding treatment decisions in breast cancer management, offering personalized risk assessments through genetic profiling of tumor tissue. These tests are utilized in oncology clinics, hospitals, and research institutions to assess cancer recurrence risk and response to adjuvant therapies. Market growth is driven by the increasing incidence of breast cancer worldwide, advancements in genomic technologies improving test accuracy, and the growing adoption of personalized medicine in oncology.

Market Growth Drivers:

The global Breast Recurrence Score Test Market is driven by several factors, including the rising incidence of breast cancer among women of various ages and ethnicities. Technological advancements, such as next-generation sequencing and multi-gene expression profiling, enhance prognostic assessments and treatment planning. The shift towards value-based healthcare models that emphasize cost-effective and tailored treatment strategies further supports market growth. Additionally, collaborative efforts among oncologists, pathologists, and molecular diagnostic companies foster innovation in test development and clinical validation.

Market Restraints:

Despite its promising growth, the Breast Recurrence Score Test Market faces challenges related to regulatory complexities, reimbursement disparities across regions, and the need for extensive clinical validation of genomic assays. Variability in test results and interpretation, along with the high costs of genetic testing technologies, can hinder widespread adoption, especially in resource-limited settings. Addressing these challenges requires continuous investment in clinical research, standardization of testing protocols, and advocacy for insurance coverage of genomic testing in oncology.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in bioinformatics, expanded genetic databases, and increased awareness among healthcare professionals about the clinical utility of genomic testing. The integration of artificial intelligence and machine learning for predictive modeling, combined with patient engagement strategies, enhances diagnostic accuracy and treatment outcomes. Additionally, the emergence of companion diagnostics for targeted therapies and decentralized testing platforms improve accessibility and patient convenience.

Key Questions Addressed in the Report:

• What are the primary growth drivers of the Breast Recurrence Score Test Market?
• Which types of recurrence score tests and genetic profiling technologies are becoming prominent in oncology?
• How are technological advancements reshaping the competitive landscape of the market?
• Who are the key players in the market, and what strategies are they using to remain competitive?
• What emerging trends and future prospects are anticipated in the Breast Recurrence Score Test Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Recurrence Score Test Market, including Exact Sciences (Genome Health Inc.), NanoString Technologies, Foundation Medicine, and others, focus on innovation, clinical validation, and strategic partnerships. These companies invest in R&D to develop new biomarkers, improve assay sensitivity, and expand testing capabilities for various breast cancer subtypes. Collaborations with oncologists, academic institutions, and patient advocacy groups enhance market penetration and promote the adoption of genomic testing solutions. Emphasis on data transparency, patient privacy, and regulatory compliance highlights the commitment to quality and ethical practices in oncology diagnostics.

Key Companies Profiled:

• Exact Sciences (Genome Health Inc.)
• NanoString Technologies, Inc.
• Foundation Medicine, Inc
• ThermoFisher Scientific
• Illumina, Inc
• Hologic Inc (Biotheranostic)
• Biocartis
• Roche Diagnostics
• Epic Sciences
• Qiagen
• Abbott
• Myriad Genetics, Inc.
• Guardant Health

Key Segments of Breast Recurrence Score Test Industry Research

Product:
• Test Kits
• Reagents & Consumables

Indication:
• Stage 1 Breast Cancer
• Stage 2 Breast Cancer
• Estrogen-Receptor-Positive Cancer
• Lymph-Node-Negative Cancer

End User:
• Hospitals
• Specialty Cancer Centers
• Diagnostic Centers
• Cancer Research Institutions

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4.Value Added Insights
4.1. Product Adoption Analysis
4.2. Product USPs/Features
4.3. Regulatory Landscape, By Country
4.4. Recent Product Approval/Launches
4.5. Disease Epidemiology
4.6. PESTLE Analysis
4.7. Value Chain Analysis
4.8. Unmet Needs
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Life Science Market Outlook
5.1.3. Global Breast Cancer Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Breast Cancer
5.2.2. Increase in Research and Development
5.2.3. Strategic Collaborations among players
5.2.4. Cost of Product
5.2.5. Adoption Rate
5.2.6. Frequency of Product Approval
5.2.7. Government Initiative
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033
6.1. Historical Market Volume (Units) Analysis, 2019-2023
6.2. Current and Future Market Volume (Units) Projections, 2024-2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Analysis
7.1. Regional Pricing Analysis By Product
7.2. Global Average Pricing Analysis Benchmark
7.3. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
8.2. Current and Future Market Size (US$ Mn) Projections, 2024-2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
9.3.1. Test Kits
9.3.2. Reagents & Consumables
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
10.3.1. Stage 1 Breast Cancer
10.3.2. Stage 2 Breast Cancer
10.3.3. Estrogen-receptor Positive Cancer
10.3.4. Lymph-node Negative Cancer
10.4. Market Attractiveness Analysis By Indication
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
11.3.1. Hospitals
11.3.2. Specialty Cancer Centers
11.3.3. Diagnostic Centers
11.3.4. Cancer Research Institutions
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2024-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Indication
13.3.4. By End User
13.4. Market Attractiveness Analysis By Region
13.4.1. By Country
13.4.2. By Product
13.4.3. By Indication
13.4.4. By End User
13.5. Market trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Indication
13.8.1.2.3. By End User
13.8.2. Canada Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Indication
13.8.2.2.3. By End User
14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis By Region
14.4.1. By Country
14.4.2. By Product
14.4.3. By Indication
14.4.4. By End User
14.5. Market trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Brazil Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Indication
14.8.1.2.3. By End User
14.8.2. Mexico Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Indication
14.8.2.2.3. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Indication
14.8.3.2.3. Type By End User
15. Europe Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Spain
15.3.1.4. Russia
15.3.1.5. Italy
15.3.1.6. BENELUX
15.3.1.7. U.K.
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis By Region
15.4.1. By Country
15.4.2. By Product
15.4.3. By Indication
15.4.4. By End User
15.5. Market trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Indication
15.8.1.2.3. By End User
15.8.2. France Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Indication
15.8.2.2.3. By End User
15.8.3. Spain Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Indication
15.8.3.2.3. Type By End User
15.8.4. Russia Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Indication
15.8.4.2.3. Type By End User
15.8.5. Italy Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Indication
15.8.5.2.3. By End User
15.8.6. BENELUX Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Indication
15.8.6.2.3. By End User
15.8.7. U.K. Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Indication
15.8.7.2.3. By End User
16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis By Region
16.4.1. By Country
16.4.2. By Product
16.4.3. By Indication
16.4.4. By End User
16.5. Market trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Indication
16.8.1.2.3. By End User
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Indication
16.8.2.2.3. By End User
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Indication
16.8.3.2.3. By End User
17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Thailand
17.3.1.4. Philippines
17.3.1.5. Malaysia
17.3.1.6. Vietnam
17.3.1.7. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis By Region
17.4.1. By Country
17.4.2. By Product
17.4.3. By Indication
17.4.4. By End User
17.5. Market trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Indication
17.8.1.2.3. By End User
17.8.2. Indonesia Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Indication
17.8.2.2.3. By End User
17.8.3. Thailand Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Indication
17.8.3.2.3. By End User
17.8.4. Philippines Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Indication
17.8.4.2.3. By End User
17.8.5. Malaysia Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Indication
17.8.5.2.3. By End User
17.8.6. Vietnam Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Indication
17.8.6.2.3. By End User
18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis By Region
18.4.1. By Country
18.4.2. By Product
18.4.3. By Indication
18.4.4. By End User
18.5. Market trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Indication
18.8.1.2.3. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Indication
18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Egypt
19.3.1.4. Israel
19.3.1.5. South Africa
19.3.1.6. Northern Africa
19.3.1.7. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis By Region
19.4.1. By Country
19.4.2. By Product
19.4.3. By Indication
19.4.4. By End User
19.5. Market trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Indication
19.8.1.2.3. By End User
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Indication
19.8.2.2.3. By End User
19.8.3. Egypt Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Indication
19.8.3.2.3. By End User
19.8.4. Israel Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Indication
19.8.4.2.3. By End User
19.8.5. South Africa Market Analysis
19.8.5.1. Introduction
19.8.5.2. Market Analysis and Forecast by Market Taxonomy
19.8.5.2.1. By Product
19.8.5.2.2. By Indication
19.8.5.2.3. By End User
19.8.6. Northern Africa Market Analysis
19.8.6.1. Introduction
19.8.6.2. Market Analysis and Forecast by Market Taxonomy
19.8.6.2.1. By Product
19.8.6.2.2. By Indication
19.8.6.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
20.3.1. Regional Footprint of Players
20.3.2. Product Footprint of Players
20.3.3. Channel Footprint of Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Key Development Analysis
21.3. Branding and Promotional Strategies, By Key Players
21.4. Competition Deep Dive
21.4.1. Exact Sciences (Genome Health Inc.)
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Key Financials
21.4.1.4. Sales Footprint
21.4.1.5. SWOT Analysis
21.4.1.6. Strategy Overview
21.4.1.6.1. Marketing Strategies
21.4.1.6.2. Channel Strategies
21.4.1.6.3. Product Strategies
21.4.2. NanoString Technologies, Inc.
21.4.2.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. Key Financials
21.4.2.4. Sales Footprint
21.4.2.5. SWOT Analysis
21.4.2.6. Strategy Overview
21.4.2.6.1. Marketing Strategies
21.4.2.6.2. Channel Strategies
21.4.2.6.3. Product Strategies
21.4.3. Foundation Medicine, Inc
21.4.3.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. Key Financials
21.4.3.4. Sales Footprint
21.4.3.5. SWOT Analysis
21.4.3.6. Strategy Overview
21.4.3.6.1. Marketing Strategies
21.4.3.6.2. Channel Strategies
21.4.3.6.3. Product Strategies
21.4.4. ThermoFisher Scientific
21.4.4.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. Key Financials
21.4.4.4. Sales Footprint
21.4.4.5. SWOT Analysis
21.4.4.6. Strategy Overview
21.4.4.6.1. Marketing Strategies
21.4.4.6.2. Channel Strategies
21.4.4.6.3. Product Strategies
21.4.5. Illumina, Inc
21.4.5.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. Key Financials
21.4.5.4. Sales Footprint
21.4.5.5. SWOT Analysis
21.4.5.6. Strategy Overview
21.4.5.6.1. Marketing Strategies
21.4.5.6.2. Channel Strategies
21.4.5.6.3. Product Strategies
21.4.6. Hologic Inc (Biotheranostic)
21.4.6.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. Key Financials
21.4.6.4. Sales Footprint
21.4.6.5. SWOT Analysis
21.4.6.6. Strategy Overview
21.4.6.6.1. Marketing Strategies
21.4.6.6.2. Channel Strategies
21.4.6.6.3. Product Strategies
21.4.7. Biocartis
21.4.7.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. Key Financials
21.4.7.4. Sales Footprint
21.4.7.5. SWOT Analysis
21.4.7.6. Strategy Overview
21.4.7.6.1. Marketing Strategies
21.4.7.6.2. Channel Strategies
21.4.7.6.3. Product Strategies
21.4.8. Roche Diagnostics
21.4.8.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. Key Financials
21.4.8.4. Sales Footprint
21.4.8.5. SWOT Analysis
21.4.8.6. Strategy Overview
21.4.8.6.1. Marketing Strategies
21.4.8.6.2. Channel Strategies
21.4.8.6.3. Product Strategies
21.4.9. Epic Sciences
21.4.9.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. Key Financials
21.4.9.4. Sales Footprint
21.4.9.5. SWOT Analysis
21.4.9.6. Strategy Overview
21.4.9.6.1. Marketing Strategies
21.4.9.6.2. Channel Strategies
21.4.9.6.3. Product Strategies
21.4.10. Qiagen
21.4.10.1. Overview
21.4.10.2. Product Portfolio
21.4.10.3. Key Financials
21.4.10.4. Sales Footprint
21.4.10.5. SWOT Analysis
21.4.10.6. Strategy Overview
21.4.10.6.1. Marketing Strategies
21.4.10.6.2. Channel Strategies
21.4.10.6.3. Product Strategies
21.4.11. Abbott
21.4.11.1. Overview
21.4.11.2. Product Portfolio
21.4.11.3. Key Financials
21.4.11.4. Sales Footprint
21.4.11.5. SWOT Analysis
21.4.11.6. Strategy Overview
21.4.11.6.1. Marketing Strategies
21.4.11.6.2. Channel Strategies
21.4.11.6.3. Product Strategies
21.4.12. Myriad Genetics, Inc
21.4.12.1. Overview
21.4.12.2. Product Portfolio
21.4.12.3. Key Financials
21.4.12.4. Sales Footprint
21.4.12.5. SWOT Analysis
21.4.12.6. Strategy Overview
21.4.12.6.1. Marketing Strategies
21.4.12.6.2. Channel Strategies
21.4.12.6.3. Product Strategies
21.4.13. Guardant Health
21.4.13.1. Overview
21.4.13.2. Product Portfolio
21.4.13.3. Key Financials
21.4.13.4. Sales Footprint
21.4.13.5. SWOT Analysis
21.4.13.6. Strategy Overview
21.4.13.6.1. Marketing Strategies
21.4.13.6.2. Channel Strategies
21.4.13.6.3. Product Strategies
22. Assumptions and Acronyms Used
23. Research Methodology